Journal of Neuro-Oncology

, Volume 75, Issue 3, pp 267–272 | Cite as

Pediatric High-grade Glioma: Molecular Genetic Clues for Innovative Therapeutic Approaches

Childhood Brain Tumors


High grade glioma remains the most intractable childhood tumor of the central nervous system. The molecular genetics of childhood high grade glioma remain largely unknown in comparison to that of their adult counterparts. In an era of molecularly targeted therapies, this dearth of knowledge will present particular challenges to those who must design and implement the next generation of therapeutic trials with these new agents. In this review, we discuss the current understanding of the molecular genetics of childhood high grade glioma and compare/contrast it to that of the adult tumors bearing the same classification for the purpose of beginning to identify the most promising therapeutic targets.


Anaplastic Astrocytoma childhood glioblastoma multiforme high grade glioma molecular genetics therapeutic targets 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kleihues, P, Cavenee, W 2000Pathology and Genetics: Tumours of the Nervous SystemIARC PressLyon, FranceGoogle Scholar
  2. 2.
    CBTRUS-(2002): Statistical report: Primary brain tumors in the united states. Published by the Central Brain Tumor Registry of the United States, 1995–1999Google Scholar
  3. 3.
    Broniscer, A, Gajjar, A 2004Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologistOncologist9197206CrossRefPubMedGoogle Scholar
  4. 4.
    Kleihues, P, Ohgaki, H 1999Primary and secondary glioblastomas: from concept to clinical diagnosisNeuro-oncol14451CrossRefPubMedGoogle Scholar
  5. 5.
    Nozaki, M, Tada, M, Kobayashi, H, Zhang, CL, Sawamura, Y, Abe, H, Ishii, N, Meir, EG 1999Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progressionNeuro-oncol112437CrossRefPubMedGoogle Scholar
  6. 6.
    Sapio, A, Morra, I, Pradotto, L, Guido, M, Schiffer, D, Mauro, A 2002Molecular genetic changes in a series of neuroepithelial tumors of childhoodJ Neurooncol59117122PubMedGoogle Scholar
  7. 7.
    Raffel, C, Frederick, L, O’Fallon, JR, Atherton-Skaff, P, Perry, A, Jenkins, RB, James, CD 1999Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with pten mutationsClin Cancer Res540854090PubMedGoogle Scholar
  8. 8.
    Bredel, M, Pollack, IF, Hamilton, RL, James, CD 1999Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhoodClin Cancer Res517861792PubMedGoogle Scholar
  9. 9.
    Sung, T, Miller, DC, Hayes, RL, Alonso, M, Yee, H, Newcomb, EW 2000Preferential inactivation of the p53 tumor suppressor pathway and lack of egfr amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomasBrain Pathol10249259PubMedGoogle Scholar
  10. 10.
    Dorward, NL, Hawkins, RA, Whittle, IR 1993Epidermal growth factor receptor activity and clinical outcome in glioblastoma and meningiomaBr J Neurosurg7197199PubMedGoogle Scholar
  11. 11.
    Newcomb, EW, Cohen, H, Lee, SR, Bhalla, SK, Bloom, J, Hayes, RL, Miller, DC 1998Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, egfr, mdm2 or bcl-2 genesBrain Pathol8655667PubMedGoogle Scholar
  12. 12.
    Zhou, YH, Tan, F, Hess, KR, Yung, WK 2003The expression of pax6, pten, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survivalClin Cancer Res933693375PubMedGoogle Scholar
  13. 13.
    Simmons, ML, Lamborn, KR, Takahashi, M, Chen, P, Israel, MA, Berger, MS, Godfrey, T, Nigro, J, Prados, M, Chang, S, Barker, FG,II, Aldape, K 2001Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patientsCancer Res6111221128PubMedGoogle Scholar
  14. 14.
    Shinojima, N, Tada, K, Shiraishi, S, Kamiryo, T, Kochi, M, Nakamura, H, Makino, K, Saya, H, Hirano, H, Kuratsu, J, Oka, K, Ishimaru, Y, Ushio, Y 2003Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiformeCancer Res6369626970PubMedGoogle Scholar
  15. 15.
    Khatua, S, Peterson, KM, Brown, KM, Lawlor, C, Santi, MR, LaFleur, B, Dressman, D, Stephan, DA, MacDonald, TJ 2003Overexpression of the egfr/fkbp12/hif-2alpha pathway identified in childhood astrocytomas by angiogenesis gene profilingCancer Res6318651870PubMedGoogle Scholar
  16. 16.
    Aldape, KD, Ballman, K, Furth, A, Buckner, JC, Giannini, C, Burger, PC, Scheithauer, BW, Jenkins, RB, James, CD 2004Immunohistochemical detection of egfrviii in high malignancy grade astrocytomas and evaluation of prognostic significanceJ Neuropathol Exp Neurol63700707PubMedGoogle Scholar
  17. 17.
    Biernat, W, Huang, H, Yokoo, H, Kleihues, P, Ohgaki, H 2004Predominant expression of mutant egfr (egfrviii) is rare in primary glioblastomasBrain Pathol14131136PubMedGoogle Scholar
  18. 18.
    Feldkamp, MM, Lala, P, Lau, N, Roncari, L, Guha, A 1999Expression of activated epidermal growth factor receptors, ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimensNeurosurgery4514421453PubMedGoogle Scholar
  19. 19.
    Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350: 2129–2139. Epub 2004 Apr 29., 2004Google Scholar
  20. 20.
    Knobbe, CB, Reifenberger, G 2003Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3′-kinase/protein kinase b (akt) signal transduction pathway in glioblastomasBrain Pathol13507518PubMedGoogle Scholar
  21. 21.
    Fleming, TP, Saxena, A, Clark, WC, Robertson, JT, Oldfield, EH, Aaronson, SA, Ali, IU 1992Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumorsCancer Res5245504553PubMedGoogle Scholar
  22. 22.
    Hermanson, M, Funa, K, Koopmann, J, Maintz, D, Waha, A, Westermark, B, Heldin, CH, Wiestler, OD, Louis, DN, Deimling, A, Nister, M 1996Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomasCancer Res56164171PubMedGoogle Scholar
  23. 23.
    Warr, T, Ward, S, Burrows, J, Harding, B, Wilkins, P, Harkness, W, Hayward, R, Darling, J, Thomas, D 2001Identification of extensive genomic loss and gain by comparative genomic hybridisation in malignant astrocytoma in children and young adultsGenes Chromosomes Cancer311522CrossRefPubMedGoogle Scholar
  24. 24.
    Lassman, AB 2004Molecular biology of gliomasCurr Neurol Neurosci Rep4228233PubMedGoogle Scholar
  25. 25.
    Pollack, IF, Finkelstein, SD, Burnham, J, Holmes, EJ, Hamilton, RL, Yates, AJ, Finlay, JL, Sposto, R 2001Age and tp53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohortCancer Res6174047407PubMedGoogle Scholar
  26. 26.
    Pollack, IF, Finkelstein, SD, Woods, J, Burnham, J, Holmes, EJ, Hamilton, RL, Yates, AJ, Boyett, JM, Finlay, JL, Sposto, R 2002Expression of p53 and prognosis in children with malignant gliomasN Engl J Med346420427CrossRefPubMedGoogle Scholar
  27. 27.
    Batchelor, TT, Betensky, RA, Esposito, JM, Pham, LD, Dorfman, MV, Piscatelli, N, Jhung, S, Rhee, D, Louis, DN 2004Age-dependent prognostic effects of genetic alterations in glioblastomaClin Cancer Res10228233PubMedGoogle Scholar
  28. 28.
    Willert, JR, Daneshvar, L, Sheffield, VC, Cogen, PH 1995Deletion of chromosome arm 17p DNA sequences in pediatric high-grade and juvenile pilocytic astrocytomasGenes Chromosomes Cancer12165172PubMedGoogle Scholar
  29. 29.
    Ueki, K, Ono, Y, Henson, JW, Efird, JT, Deimling, A, Louis, DN 1996Cdkn2/p16 or rb alterations occur in the majority of glioblastomas and are inversely correlatedCancer Res56150153PubMedGoogle Scholar
  30. 30.
    Newcomb, EW, Alonso, M, Sung, T, Miller, DC 2000Incidence of p14arf gene deletion in high-grade adult and pediatric astrocytomasHum Pathol31115119CrossRefPubMedGoogle Scholar
  31. 31.
    Fan, X, Munoz, J, Sanko, SG, Castresana, JS 2002Pten, dmbt1, and p16 alterations in diffusely infiltrating astrocytomasInt J Oncol21667674PubMedGoogle Scholar
  32. 32.
    Park, SH, Jung, KC, Ro, JY, Kang, GH, Khang, SK 20005′ cpg island methylation of p16 is associated with absence of p16 expression in glioblastomasJ Korean Med Sci15555559PubMedGoogle Scholar
  33. 33.
    Shu, H, Zhou, D, Li, Z, Lin, Z 2002Multiple suppressor gene p16 of human brain gliomasZhonghua Yu Fang Yi Xue Za Zhi36517518PubMedGoogle Scholar
  34. 34.
    Souza Nascimento, P, Maciel, CM, Kawamura, MT, Oliveira, JA, Teixeira, A, Carvalho Mda, G, Alves, G 2001Molecular analysis of cdkn2 (p16) in gliomas associated with clinical dataOncol Rep810391043PubMedGoogle Scholar
  35. 35.
    Fan, X, Gomez, L, Nistal, M, Sierrasesumaga, L, Castresana, JS 1998Differential polymerase chain reaction: a technical comparison of three methods for the detection of cdk4 gene amplification in glioblastomasInt J Oncol13963966PubMedGoogle Scholar
  36. 36.
    Rollbrocker, B, Waha, A, Louis, DN, Wiestler, OD, Deimling, A 1996Amplification of the cyclin-dependent kinase 4 (cdk4) gene is associated with high cdk4 protein levels in glioblastoma multiformeActa Neuropathol (Berl)927074Google Scholar
  37. 37.
    Petronio, J, He, J, Fults, D, Pedone, C, James, CD, Allen, JR 1996Common alternative gene alterations in adult malignant astrocytomas, but not in childhood primitive neuroectodermal tumors: P 16ink4 homozygous deletions and cdk4 gene amplificationsJ Neurosurg8410201023PubMedGoogle Scholar
  38. 38.
    Kraus, JA, Felsberg, J, Tonn, JC, Reifenberger, G, Pietsch, T 2002Molecular genetic analysis of the tp53, pten, cdkn2a, egfr, cdk4 and mdm2 tumour-associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhoodNeuropathol Appl Neurobiol28325333PubMedGoogle Scholar
  39. 39.
    Rasheed, BK, Stenzel, TT, McLendon, RE, Parsons, R, Friedman, AH, Friedman, HS, Bigner, DD, Bigner, SH 1997Pten gene mutations are seen in high-grade but not in low-grade gliomasCancer Res5741874190PubMedGoogle Scholar
  40. 40.
    Cheng, Y, Ng, HK, Zhang, SF, Ding, M, Pang, JC, Zheng, J, Poon, WS 1999Genetic alterations in pediatric high-grade astrocytomasHum Pathol3012841290CrossRefPubMedGoogle Scholar
  41. 41.
    Alonso, M, Hamelin, R, Kim, M, Porwancher, K, Sung, T, Parhar, P, Miller, DC, Newcomb, EW 2001Microsatellite instability occurs in distinct subtypes of pediatric but not adult central nervous system tumorsCancer Res6121242128PubMedGoogle Scholar
  42. 42.
    Szybka, M, Bartkowiak, J, Zakrzewski, K, Polis, L, Liberski, P, Kordek, R 2003Microsatellite instability and expression of DNA mismatch repair genes in malignant astrocytic tumors from adult and pediatric patientsClin Neuropathol22180186PubMedGoogle Scholar
  43. 43.
    Martinez, R, Schackert, HK, Plaschke, J, Baretton, G, Appelt, H, Schackert, G 2004Molecular mechanisms associated with chromosomal and microsatellite instability in sporadic glioblastoma multiformeOncology66395403CrossRefPubMedGoogle Scholar
  44. 44.
    Gurney JG, Smith MA, Bunin GR: Cns and miscellaneous intracranial and intraspinal neoplasms. National Cancer Institute SEER program, Bethesda, MD, 1999Google Scholar
  45. 45.
    Fisher, PG, Breiter, SN, Carson, BS, Wharam, MD, Williams, JA, Weingart, JD, Foer, DR, Goldthwaite, PT, Tihan, T, Burger, PC 2000A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entitiesCancer8915691576CrossRefPubMedGoogle Scholar
  46. 46.
    Zimmerman, RA 1996Neuroimaging of primary brainstem gliomas: diagnosis and coursePediatr Neurosurg254553PubMedGoogle Scholar
  47. 47.
    Louis, DN, Rubio, MP, Correa, KM, Gusella, JF, Deimling, A 1993Molecular genetics of pediatric brain stem gliomas. Application of pcr techniques to small and archival brain tumor specimensJ Neuropathol Exp Neurol52507515PubMedGoogle Scholar
  48. 48.
    Gilbertson, RJ, Hill, DA, Hernan, R, Kocak, M, Geyer, R, Olson, J, Gajjar, A, Rush, L, Hamilton, RL, Finkelstein, SD, Pollack, IF 2003Erbb1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem gliomaClin Cancer Res936203624PubMedGoogle Scholar
  49. 49.
    Husain, SR, Puri, RK 2003Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: From bench to bedsideJ Neurooncol653748CrossRefPubMedGoogle Scholar
  50. 50.
    Debinski, W, Gibo, DM, Hulet, SW, Connor, JR, Gillespie, GY 1999Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomasClin Cancer Res5985990PubMedGoogle Scholar
  51. 51.
    Kawakami, M, Kawakami, K, Takahashi, S, Abe, M, Puri, RK 2004Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumorsCancer10110361042CrossRefPubMedGoogle Scholar
  52. 52.
    Kunwar, S 2003Convection enhanced delivery of il13-pe38qqr for treatment of recurrent malignant glioma: presentation of interim findings from ongoing phase 1 studiesActa Neurochir Suppl88105111PubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  1. 1.Division of Hematology/OncologyCenter for Cancer and Immunology Research, Children’s National Medical CenterWashingtonUSA

Personalised recommendations